Literature DB >> 28486102

Tumor Microenvironment: No Effector T Cells without Dendritic Cells.

Christina Pfirschke1, Marie Siwicki1, Hsin-Wei Liao1, Mikael J Pittet2.   

Abstract

Successful antitumor immunity is thought to require T cell entry into tumors, though mechanisms regulating this process remain unclear. In this issue of Cancer Cell, Spranger et al. indicate that chemokines produced by intratumoral Batf3 dendritic cells are critical for effector T cell recruitment. The findings have implications for immunotherapy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28486102     DOI: 10.1016/j.ccell.2017.04.007

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  19 in total

Review 1.  Dendritic Cell-Based Cancer Vaccines.

Authors:  Patricia M Santos; Lisa H Butterfield
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.

Authors:  Liye Zhou; Tenny Mudianto; Xiaojing Ma; Rachel Riley; Ravindra Uppaluri
Journal:  Clin Cancer Res       Date:  2019-09-27       Impact factor: 12.531

Review 3.  Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes.

Authors:  Bruna Corradetti; Simone Pisano; Robert Steven Conlan; Mauro Ferrari
Journal:  J Pharmacol Exp Ther       Date:  2019-02-08       Impact factor: 4.030

4.  Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases.

Authors:  Zongmin Zhao; Anvay Ukidve; Vinu Krishnan; Alexandra Fehnel; Daniel C Pan; Yongsheng Gao; Jayoung Kim; Michael A Evans; Abhirup Mandal; Junling Guo; Vladimir R Muzykantov; Samir Mitragotri
Journal:  Nat Biomed Eng       Date:  2020-11-16       Impact factor: 25.671

5.  CD8+ T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity.

Authors:  Roman V Uzhachenko; Anil Shanker
Journal:  Front Immunol       Date:  2019-08-13       Impact factor: 7.561

Review 6.  Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment.

Authors:  Lisa Haas; Anna C Obenauf
Journal:  Front Immunol       Date:  2019-11-28       Impact factor: 7.561

7.  Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy.

Authors:  Muhammad Zaeem Noman; Santiago Parpal; Kris Van Moer; Malina Xiao; Yasmin Yu; Jenny Viklund; Angelo De Milito; Meriem Hasmim; Martin Andersson; Ravi K Amaravadi; Jessica Martinsson; Guy Berchem; Bassam Janji
Journal:  Sci Adv       Date:  2020-04-29       Impact factor: 14.136

8.  Editorial: Lymphocyte Functional Crosstalk and Regulation.

Authors:  Raghvendra M Srivastava; Francesco M Marincola; Anil Shanker
Journal:  Front Immunol       Date:  2019-12-10       Impact factor: 7.561

Review 9.  E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT.

Authors:  Michele Sommariva; Nicoletta Gagliano
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

10.  Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib.

Authors:  Vincenzo Ricci; Cristina Granetto; Antonella Falletta; Matteo Paccagnella; Andrea Abbona; Elena Fea; Teresa Fabozzi; Cristiana Lo Nigro; Marco Carlo Merlano
Journal:  World J Gastrointest Oncol       Date:  2020-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.